Accessibility Menu
Excellerant logo

Excellerant(OTC) EXCL

Market Cap$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-100%
5 Year-100%
1 Year+9,900%
1 Month+0%
$0.00
+0.00%
+0.00Today
Excellerant last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-13
Excellerant stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002026-03-24
1 month+0%USD 0.002026-03-24
3 month+0%USD 0.002026-03-24
Year to date+0%USD 0.002025-12-22
1 year+9,900%USD 0.002025-05-29
3 year-83.33%USD 0.002023-06-28
5 year-99.99%USD 1.752021-03-22
Since inception-99.99%USD 1.502021-03-19

Excellerant Financials at a Glance

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$13.80K

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-1863.92 (Low)

Price

$0.00

Volume

2

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

EXCL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Excellerant

Excellerant, Inc. is an emerging firm specializing in health-related consultation and travel coordination services for corporate clients and private individuals. Established in 2019 and based in Brussels, Belgium, the company aims to provide comprehensive advisory services that encompass both conventional and complementary medical practices.

Products and Services
  • Diverse health-related consultation services
  • Travel coordination for medical treatments
  • Advisory on advanced medical technologies
Growth Outlook
  • Plans to expand service offerings in the healthcare sector
  • Targeting increased demand for health-related travel coordination
  • Potential partnerships with healthcare facilities to enhance service delivery
Financial Highlights
  • Trailing twelve months (TTM) revenue of $0, indicating early-stage operations
  • Recent quarterly net income of -$8,328, reflecting initial investment phases
  • Current market capitalization of $1,130, showcasing growth potential
Excellerant, Inc. operates in a niche market with significant growth potential, particularly in the health consultation and travel coordination sectors. The company's focus on both conventional and complementary medical practices positions it well to meet the evolving needs of clients seeking comprehensive healthcare solutions. Despite current financial challenges, including a TTM revenue of $0 and recent net losses, the company is strategically positioned to capitalize on increasing demand for health-related services. The planned expansion of service offerings and potential partnerships with healthcare facilities could drive future growth, making Excellerant, Inc. an intriguing prospect for investors interested in the healthcare sector.
AI Generated • Aug 23, 2026

Industry

Healthcare Providers and Services

CEO

Mirsad Devic

Headquarters

Brussels, BU 1000, BE

EXCL Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

106.26%

Return on Capital

N/A

Return on Assets

0.00%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

5.65M

Volume

2

Avg. Volume

0.031

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$13.80K

EBITDA

-$43.63K

Operating Cash Flow

-$34.68K

Capital Expenditure

$0.00

Free Cash Flow

-$34.68K

Cash & ST Invst.

$0.00

Total Debt

$13.94K

Excellerant Performance Analysis

Excellerant annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-09-30USD 0N/A
Excellerant sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12020-12-31N/A
Q22021-03-31N/A
Q32021-06-30N/A
Q42021-09-30N/A
Excellerant annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-09-30USD -0.00N/A
Excellerant sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12020-12-31-455.6%
Q22021-03-31186.0%
Q32021-06-30-137.2%
Q42021-09-306.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q4 2021YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$600.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$600.00

N/A

Employees

1

N/A

Net Income

-$8.33K

-57.1%

EBITDA

-$8.33K

-66.1%

Quarterly Fundamentals

Name
Q4 2021YOY CHG

Total Cash

$0.00

N/A

Total Debt

$13.94K

+28.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$13.94K

+28.6%

Return on Assets

0.00%

N/A

Return on Invested Capital

69.39%

N/A

Free Cash Flow

-$3.78K

-64.4%

Operating Cash Flow

-$3.78K

-47.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LRDRLaredo Resources Corp.
$0.08+161.56%
RYSMFRoyal Standard Minerals Inc.
$0.00+0.00%
CCVLCrown Cap Ventures Ltd.
$0.00+0.00%
CKCBClark County Bancorporation
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
IRENIren
$40.53+0.02%
NVDANvidia
$227.98+0.09%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$45.35-0.06%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$123.05+0.06%

Questions About EXCL

What is the current price of Excellerant?

Excellerant is trading at $0.00 per share.

What is the 52-week range for Excellerant?

Over the past 52 weeks, Excellerant has traded between $0.00 and $0.00.

How much debt does Excellerant have?

As of the most recent reporting period, Excellerant reported total debt of $13.94K.

How much cash does Excellerant have on hand?

Excellerant reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Excellerant’s dividend yield?

Excellerant does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.